Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
385M
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
138M
-
Shares change
-
+4.65M
-
Total reported value, excl. options
-
$2.8B
-
Value change
-
+$99.8M
-
Put/Call ratio
-
0.99
-
Number of buys
-
64
-
Number of sells
-
-39
-
Price
-
$20.35
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q1 2019
124 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q1 2019.
Moderna, Inc. - COMMON STOCK (MRNA) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 138M shares
of 385M outstanding shares and own 35.95% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (58.8M shares), Viking Global Investors LP (16.7M shares), FMR LLC (15.2M shares), Artal Group S.A. (5.01M shares), BB BIOTECH AG (4.79M shares), FIDUCIARY TRUST CO (4.31M shares), MORGAN STANLEY (3.41M shares), WELLINGTON MANAGEMENT GROUP LLP (3.05M shares), BAILLIE GIFFORD & CO (2.58M shares), and WADDELL & REED FINANCIAL INC (1.73M shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.